東方生物(688298.SH):公司及高管收到浙江證監局警示函
格隆匯3月8日丨東方生物(688298.SH)發佈公告,該公司於2020年3月6日收到中國證監會浙江證監局《關於對浙江東方基因生物製品股份有限公司、王曉波採取出具警示函措施的決定》(〔2020〕14號)。
根據披露,2020年2月23日該公司發佈《浙江東方基因生物製品股份有限公司澄清公告》(編號2020-006,以下簡稱《澄清公告》),隨後於當日發佈《浙江東方基因生物製品股份有限公司關於澄清公告的補充公告》(編號2020-007,以下簡稱《補充公告》)。該公司發佈的《澄清公告》信息披露不準確,與《補充公告》不一致。該公司董事會祕書王曉波未經內部審批程序發佈與事實不符的公告,反映出該公司信息披露事務管理制度未能有效執行。
公告表示,該公司及相關人員收到警示函後,高度重視警示函中指出的相關問題,該公司及相關人員亦將認真吸取經驗教訓,組織相關人員加強對《上市公司治理準則》、《上市公司信息披露管理辦法》以及其他相關法律、法規的學習,不斷提高公司信息披露質量,維護公司及全體股東利益,促進公司健康、穩定和持續發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.